Cormorant Asset Management, LP Q4 2020 Filing

Filed February 16, 2021

Portfolio Value

$4.2T

Holdings

104

Report Date

Q4 2020

Filing Type

13F-HR

All Holdings (104 positions)

#StockSharesValue% PortfolioType
101
IMV1EURIMV INC
234,374$716.0M0.02%
102
NKTREURNEKTAR THERAPEUTICS
40,000$680.0M0.02%
103
ASNSUSDX4 PHARMACEUTICALS INC
103,980$669.0M0.02%
104
NERVGBPMINERVA NEUROSCIENCES INC
200,000$468.0M0.01%
PreviousPage 2 of 2